Lymphocyte Membrane Antigen Receptors Reside in Discrete Protein Islands
|
By LabMedica International staff writers Posted on 27 Sep 2015 |

Image: Researchers previously assumed that receptors such as the antigen receptors of class Immunoglobulin M and Immunoglobulin D are freely diffusing and equally distributed molecules on the membrane. However, the new study shows that these antigen receptors are organized in different membrane compartments, also called \"protein islands\", with diameters of 150–200 nanometers (Photo courtesy of Reth Research Group, BIOSS Centre for Biological Signaling Studies of the University of Freiburg).
By applying several advanced imaging techniques, researchers have resolved the distribution of B-cell antigen receptors on the membranes of immune system lymphocytes.
The B-cell antigen receptors (BCRs) play an important role in the clonal selection of B-cells and their differentiation into antibody-secreting plasma cells. Mature B-cells have both immunoglobulin M (IgM) and IgD types of BCRs, which have identical antigen-binding sites and are both associated with the signaling subunits Ig-alpha and Ig-beta, but differ in their membrane-bound heavy chain isoforms.
Investigators at the BIOSS Centre for Biological Signaling Studies of the University of Freiburg (Germany) applied, two-color direct stochastic optical reconstruction microscopy (dSTORM), transmission electron microscopy (TEM), and the Fab-based proximity-ligation assay (Fab-PLA) to resolve the location and distribution of BCRs in the mature lymphocyte membrane.
Results published in the September 15, 2015, issue of the journal Science Signaling revealed that in contrast to the assumption that BCRs—like all proteins in the membrane—were freely diffusing molecules, dSTORM showed that IgM-BCRs and IgD-BCRs resided in the plasma membrane in different protein islands with average sizes of 150 and 240 nanometers, respectively. Upon B-cell activation, the BCR protein islands became smaller and more dispersed such that the IgM-BCRs and IgD-BCRs were found in close proximity to each other. Moreover, specific stimulation of one class of BCR had minimal effects on the organization of the other. These conclusions were supported by the findings from two-marker transmission electron microscopy and proximity ligation assays.
These results provide direct evidence for the nanoscale compartmentalization of the lymphocyte membrane. In addition, they suggest that upon B-cell activation, the different IgM and IgD protein islands form complexes, which allow the exchange of lipids and proteins. This could be the basis for the association of IgM with Raft-associated lipids and proteins, which is a well-known hallmark of B-cell activation.
The current study was a component of the University of Frieberg's BIOSS nanoscale explorer program (BiNEP), which is dedicated to developing better methods to resolve nano-structures that are smaller than the 250 nanometer diffraction limit of visible light.
Related Links:
BIOSS Centre for Biological Signaling Studies of the University of Freiburg
The B-cell antigen receptors (BCRs) play an important role in the clonal selection of B-cells and their differentiation into antibody-secreting plasma cells. Mature B-cells have both immunoglobulin M (IgM) and IgD types of BCRs, which have identical antigen-binding sites and are both associated with the signaling subunits Ig-alpha and Ig-beta, but differ in their membrane-bound heavy chain isoforms.
Investigators at the BIOSS Centre for Biological Signaling Studies of the University of Freiburg (Germany) applied, two-color direct stochastic optical reconstruction microscopy (dSTORM), transmission electron microscopy (TEM), and the Fab-based proximity-ligation assay (Fab-PLA) to resolve the location and distribution of BCRs in the mature lymphocyte membrane.
Results published in the September 15, 2015, issue of the journal Science Signaling revealed that in contrast to the assumption that BCRs—like all proteins in the membrane—were freely diffusing molecules, dSTORM showed that IgM-BCRs and IgD-BCRs resided in the plasma membrane in different protein islands with average sizes of 150 and 240 nanometers, respectively. Upon B-cell activation, the BCR protein islands became smaller and more dispersed such that the IgM-BCRs and IgD-BCRs were found in close proximity to each other. Moreover, specific stimulation of one class of BCR had minimal effects on the organization of the other. These conclusions were supported by the findings from two-marker transmission electron microscopy and proximity ligation assays.
These results provide direct evidence for the nanoscale compartmentalization of the lymphocyte membrane. In addition, they suggest that upon B-cell activation, the different IgM and IgD protein islands form complexes, which allow the exchange of lipids and proteins. This could be the basis for the association of IgM with Raft-associated lipids and proteins, which is a well-known hallmark of B-cell activation.
The current study was a component of the University of Frieberg's BIOSS nanoscale explorer program (BiNEP), which is dedicated to developing better methods to resolve nano-structures that are smaller than the 250 nanometer diffraction limit of visible light.
Related Links:
BIOSS Centre for Biological Signaling Studies of the University of Freiburg
Latest BioResearch News
- Telomere Length Abnormalities Linked to Lymphoma Development
- Biomarker Signals Chemotherapy Resistance in Relapsed Small Cell Lung Cancer
- Inflammatory Gene Signature Links Metabolic Disease to Pancreatic Cancer Recurrence
- Study Links Abnormal Gene Splicing to Treatment Response in Metastatic Kidney Cancer
- Research Reveals How Some Aplastic Anemia Patients Recover Bone Marrow Function
- New Molecular Insights Support Diagnosis of Hodgkin Lymphoma
- Epigenetic Signals and Blood Markers Aid Chronic Fatigue Syndrome Diagnosis
- Microenvironment Biomarkers Could Enable Early Lung Cancer Detection
- Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
- Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
- Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
- Single-Cell Method Measures RNA and Proteins to Reveal Immune Responses
- Study Links Midlife Vitamin D to Lower Tau in Alzheimer's
- International Consensus Standardizes Tumor Microbiota Detection and Reporting
- Common Metablolic Enzyme Could Predict Response to Cancer Immunotherapy
- Newly Identfied Genetic Variants in MND Support Prognosis and Family Testing
Channels
Clinical Chemistry
view channel
Ultrasensitive Test Detects Key Biomarker of Frontotemporal Dementia Subtype
Dementia affects more than 57 million people worldwide and is projected to nearly double within two decades, straining health systems and families. While biomarkers now enable accurate identification of... Read more
Routine Blood Tests Years Before Pregnancy Could Identify Preeclampsia Risk
High blood pressure during pregnancy is common and can progress to pre-eclampsia, making close monitoring at antenatal visits essential. However, most risk assessment begins only after pregnancy has started.... Read moreMolecular Diagnostics
view channel
Finger-Prick Blood Test Aids Early Tuberculosis Detection and Risk Stratification
Household contacts of people with tuberculosis face an estimated 2% risk of developing disease, yet most are asymptomatic at the time of screening. Early-stage cases are often missed because symptom checks... Read more
Urine Test Beats MRI in Identifying Prostate Cancer Upgrading During Active Surveillance
Active surveillance is common for men with low-risk prostate cancer, yet deciding when to repeat biopsy remains challenging. Prostate-specific antigen (PSA) testing and magnetic resonance imaging (MRI)... Read moreHematology
view channel
Stem Cell Biomarkers May Guide Precision Treatment in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is an aggressive blood cancer that most often affects older adults and still carries a poor prognosis despite therapeutic advances. Venetoclax-based regimens have improved... Read more
Advanced CBC-Derived Indices Integrated into Hematology Platforms
Diatron, a STRATEC brand, has introduced six advanced hematological indices on its Aquila, Aquarius 3, and Abacus 5 hematology analyzers. The new Research Use Only (RUO) indices include Neutrophil-to-Lymphocyte... Read moreImmunology
view channel
Point-of-Care Tests Could Expand Access to Mpox Diagnosis
Mpox outbreaks in non-endemic regions have underscored the need for rapid, accessible diagnostics to limit transmission. Polymerase chain reaction (PCR) remains the clinical reference, yet it depends on... Read more
T-Cell Senescence Profiling May Predict CAR T Responses
Chimeric antigen receptor (CAR) T-cell therapy can deliver striking, durable remissions, yet many patients experience minimal or no benefit. The quality of patient-derived cytotoxic T lymphocytes used... Read moreMicrobiology
view channel
Rapid Antigen Biosensor Detects Active Tuberculosis in One Hour
Tuberculosis remains a major global health challenge and continues to drive significant morbidity and mortality. The World Health Organization’s 2024 global report cites it as the leading cause of death... Read more
Oral–Gut Microbiome Signatures Identify Early Gastric Cancer
Early detection of gastric cancer could be advanced by scalable screening strategies using minimally invasive sampling. Saliva collection is noninvasive and cost-effective, supporting wider adoption... Read morePathology
view channel
FDA Clears AI Digital Pathology Tool for Breast Cancer Risk Stratification
Risk assessment at diagnosis is central to guiding therapy for early-stage, hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) invasive breast cancer, where overtreatment... Read more
New AI Tool Reveals Hidden Genetic Signals in Routine H&E Slides
Pathologists worldwide rely on hematoxylin and eosin (H&E) slides to examine tissue architecture, yet these stains do not reveal the underlying molecular activity that often drives disease.... Read moreTechnology
view channel
Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing
Latent tuberculosis remains a substantial testing workload for clinical laboratories as screening programs expand. Despite this growth, only about 40% of testing has shifted from traditional skin tests... Read more
Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response
Pancreatic cancer remains one of the hardest malignancies to treat because tumors are embedded within a dense microenvironment that shapes growth and therapy response. Standard laboratory models often... Read moreIndustry
view channel
Roche to Acquire PathAI for Up to $1.05 Billion to Strengthen AI Diagnostics Portfolio
Roche has entered into a definitive merger agreement to acquire PathAI, a company focused on digital pathology and artificial intelligence for pathology laboratories and the biopharma industry.... Read more








